SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

BSE Healthcare Companies

BSE Sensex 76888.00
52.22 (0.07%)

The BSE Healthcare Index is designed to reflect the behaviour and performance of mid market capitalization companies. S&P BSE Mid Cap includes all companies forming part of mid cap universe on BSE. Look for Green and Orange companies for investing. Bookmark this page for your easy reference in future.

See MoneyWorks4me's rating on Quality, Valuation, Price Trend and Overall Rating to take informed stock investing decisions. Decizen :- Q: Quality, V: Valuation, PT: Price Trend

Filter

BSE Healthcare companies as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	CMP	Price Change (%)	Market Cap (Cr)	52Week High	52Week Low	ROE(%)	P/E	P/BV	EV/ EBITDA	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Cipla Ltd	Q V PT	1,439	2.04%	1,13,894 Large Cap	1,672 23 Oct, 25	1,166 02 Apr, 26	11.57	33.79	3.24	18.28	8.01	10.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Dr. Agarwals Health Care Ltd	Q V PT	483	1.50%	15,076 Small Cap	568 16 Oct, 25	402 27 Mar, 26	4.70	113.19	7.44	24.60	26.38	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Kovai Medical Center & Hospital Ltd	Q V PT	5,944	1.46%	6,411 Small Cap	6,725 27 Oct, 25	5,010 30 Mar, 26	21.22	26.22	4.86	13.77	14.01	17.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Caplin Point Laboratories Ltd	Q V PT	2,659	1.38%	19,939 Small Cap	2,700 15 Jul, 26	1,502 30 Mar, 26	20.20	31.09	5.56	22.04	17.55	21.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Nephrocare Health Services Ltd	Q V+ PT	690	1.27%	6,853 Small Cap	768 12 Jun, 26	445 19 Dec, 25	-1.18	0.00	7.19	64.00	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Jupiter Life Line Hospitals Ltd	Q V PT	331	1.19%	10,728 Small Cap	330 27 Jul, 26	230 02 Mar, 26	12.32	56.06	6.67	31.98	21.03	54.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Narayana Hrudayalaya Ltd	Q V PT	2,078	1.17%	41,974 Mid Cap	2,094 17 Nov, 25	1,564 30 Mar, 26	20.68	52.10	9.25	25.71	25.04	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Rubicon Research Ltd	Q V+ PT	1,580	1.13%	25,860 Small Cap	1,577 27 Jul, 26	571 24 Oct, 25	28.27	137.43	19.11	80.47	32.49	25.95	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Indegene Ltd	Q V+ PT	512	0.83%	12,241 Small Cap	597 17 Sep, 25	415 23 Mar, 26	14.49	30.52	3.96	17.16	29.44	13.80	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Metropolis Healthcare Ltd	Q V PT	582	0.78%	11,981 Small Cap	600 14 May, 26	413 02 Apr, 26	11.92	63.05	7.92	27.99	9.22	2.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Kopran Ltd	Q V PT	203	0.74%	975 Small Cap	219 29 May, 26	107 30 Mar, 26	5.88	32.07	2.18	20.56	8.61	14.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	KMC Speciality Hospitals (India) Ltd	Q V PT	131	0.69%	2,127 Small Cap	146 09 Jul, 26	62.50 28 Jul, 25	13.91	45.52	10.11	23.05	19.21	12.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Novartis India Ltd	Q V+ PT	1,640	0.66%	4,023 Small Cap	1,778 23 Jul, 26	750 21 Jan, 26	13.21	41.14	4.73	24.19	-4.06	54.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Blue Jet Healthcare Ltd	Q V PT	579	0.56%	10,906 Small Cap	835 11 Aug, 25	325 30 Mar, 26	28.99	44.01	5.05	29.65	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Gujarat Kidney And Super Speciality Ltd	Q V PT	128	0.55%	1,004 Small Cap	148 25 May, 26	98.25 23 Jan, 26	17.08	101.45	4.08	58.20	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Lincoln Pharmaceuticals Ltd	Q V PT	584	0.52%	1,163 Small Cap	770 27 May, 26	440 04 Feb, 26	11.86	13.23	1.53	8.65	10.63	11.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Strides Pharma Science Ltd	Q V+ PT	1,049	0.50%	9,623 Small Cap	1,231 12 May, 26	770 29 Jan, 26	1.71	52.40	2.93	26.29	3.25	-0.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Laurus Labs Ltd	Q V+ PT	1,721	0.39%	92,623 Mid Cap	1,734 27 Jul, 26	811 12 Aug, 25	17.86	84.70	16.43	45.46	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Gufic Biosciences Ltd	Q V PT	383	0.38%	3,826 Small Cap	448 30 Jun, 26	268 30 Mar, 26	12.60	60.59	5.76	27.05	16.69	24.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Sun Pharmaceutical Industries Ltd	Q V+ PT	1,981	0.37%	4,73,509 Large Cap	1,977 27 Jul, 26	1,547 26 Sep, 25	14.80	41.25	5.67	23.65	11.78	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Cohance Lifesciences Ltd	Q V+ PT	431	0.33%	16,444 Small Cap	1,038 08 Sep, 25	268 09 Mar, 26	13.87	91.75	4.20	35.90	7.51	-3.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Innova Captab Ltd	Q V PT	969	0.31%	5,527 Small Cap	1,033 15 Jul, 26	608 02 Mar, 26	9.48	66.04	6.23	35.51	25.90	14.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Nectar Lifesciences Ltd	Q V PT	10.45	0.29%	202 Small Cap	22.49 23 Dec, 25	9.20 01 Apr, 26	-11.82	0.00	0.35	-1.83	-6.71	-232.05	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Abbott India Ltd	Q V PT	27,890	0.28%	59,102 Mid Cap	35,280 30 Jul, 25	25,164 27 Apr, 26	34.24	38.08	12.45	26.07	9.96	17.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Granules India Ltd	Q V+ PT	845	0.27%	20,878 Small Cap	910 16 Jul, 26	433 06 Aug, 25	10.58	51.82	5.09	27.99	2.07	-5.88	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Indraprastha Medical Corporation Ltd	Q V+ PT	370	0.27%	3,382 Small Cap	640 06 Nov, 25	342 27 Jan, 26	30.04	18.42	4.57	10.55	10.30	29.46	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Procter & Gamble Health Ltd	Q V+ PT	6,798	0.25%	11,257 Small Cap	6,955 15 Jul, 26	4,700 06 Apr, 26	43.64	34.43	21.46	23.36	4.31	11.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Dr. Lal Pathlabs Ltd	Q V PT	1,830	0.22%	30,607 Small Cap	1,894 27 Jul, 26	1,272 23 Mar, 26	22.79	56.18	11.90	32.17	12.18	13.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Aster DM Quality Care Ltd	Q V+ PT	805	0.19%	70,000 Mid Cap	848 12 Jun, 26	520 04 Feb, 26	7.55	180.35	14.20	67.58	-13.71	0.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Healthcare Global Enterprises Ltd	Q V+ PT	678	0.18%	10,110 Small Cap	799 29 Oct, 25	513 30 Mar, 26	2.34	693.42	6.30	37.61	13.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
31	Glaxosmithkline Pharmaceuticals Ltd	Q V PT	2,554	0.16%	43,202 Mid Cap	3,203 31 Jul, 25	2,088 12 Jun, 26	45.95	41.70	18.92	28.74	5.49	17.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Suraksha Diagnostic Ltd	Q V PT	250	0.16%	1,300 Small Cap	334 16 Sep, 25	224 30 Mar, 26	16.38	40.40	5.31	12.95	9.86	-51.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Park Medi World Ltd	Q V+ PT	280	0.16%	12,060 Small Cap	305 01 Jul, 26	138 18 Dec, 25	6.55	329.35	14.02	191.05	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Glenmark Pharmaceuticals Ltd	Q V+ PT	2,197	0.10%	61,928 Mid Cap	2,471 29 Apr, 26	1,794 28 Oct, 25	15.43	45.47	5.89	12.07	4.60	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Vimta Labs Ltd	Q V+ PT	587	0.09%	2,620 Small Cap	903 05 Sep, 25	377 30 Mar, 26	18.29	32.89	5.57	16.38	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Yatharth Hospital & Trauma Care Services Ltd	Q V PT	845	0.09%	8,132 Small Cap	890 25 May, 26	538 27 Jan, 26	7.42	85.24	5.02	49.92	27.90	137.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Pfizer Ltd	Q V PT	4,693	0.06%	21,456 Small Cap	5,879 18 Aug, 25	4,361 29 Jun, 26	17.97	29.70	5.11	16.80	2.39	8.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Mankind Pharma Ltd	Q V PT	2,552	0.03%	1,05,357 Mid Cap	2,670 22 Sep, 25	1,910 23 Mar, 26	13.55	51.71	6.44	32.38	13.54	13.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Natco Pharma Ltd	Q V PT	927	0.03%	16,606 Small Cap	1,226 12 May, 26	789 30 Sep, 25	26.69	11.71	1.80	9.09	18.26	32.57	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Sanofi Consumer Healthcare India Ltd	Q V+ PT	4,678	0.00%	10,773 Small Cap	5,493 05 Aug, 25	3,951 02 Mar, 26	71.09	41.77	23.84	29.49	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Max Healthcare Institute Ltd	Q V+ PT	1,115	0.00%	1,08,476 Mid Cap	1,302 13 Aug, 25	904 07 Apr, 26	14.68	75.20	10.23	46.01	27.27	155.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Dr Agarwals Eye Hospital Ltd	Q V PT	5,041	0.00%	2,436 Small Cap	6,392 02 Jan, 26	4,231 28 Aug, 25	29.56	34.75	7.04	16.62	17.68	31.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Health X Platform Ltd	Q V PT	310	0.00%	985 Small Cap	375 13 Jan, 26	253 30 Mar, 26	-0.26	0.00	3.64	-1233.10	109.54	-201.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Sigachi Industries Ltd	Q V+ PT	25.93	0.00%	991 Small Cap	46.70 15 Sep, 25	16.74 30 Mar, 26	9.61	0.00	2.08	18.42	24.05	7.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Aurobindo Pharma Ltd	Q V+ PT	1,549	-0.02%	89,115 Mid Cap	1,636 03 Jul, 26	1,017 02 Sep, 25	8.24	36.90	3.92	25.31	-3.95	-0.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Lupin Ltd	Q V PT	2,409	-0.03%	1,10,189 Mid Cap	2,530 16 Jul, 26	1,839 06 Aug, 25	26.43	20.66	4.92	11.95	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Sanofi India Ltd	Q V PT	3,368	-0.04%	7,760 Small Cap	5,922 31 Jul, 25	3,058 29 May, 26	42.80	25.05	9.95	15.50	-8.74	-7.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Laxmi Dental Ltd	Q V PT	218	-0.05%	1,198 Small Cap	471 28 Jul, 25	156 30 Mar, 26	8.81	72.96	4.85	31.06	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Themis Medicare Ltd	Q V PT	108	-0.09%	995 Small Cap	148 25 Sep, 25	65.00 30 Mar, 26	7.37	0.00	3.71	111.19	15.00	7.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Thyrocare Technologies Ltd	Q V+ PT	583	-0.09%	9,287 Small Cap	617 27 Jul, 26	343 23 Mar, 26	28.49	52.68	14.76	30.93	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Cipla	1,438.55	2.04%
Dr. Agarwals Health	482.70	1.50%
Kovai Medical Center	5,943.95	1.46%
Caplin Point Labs.	2,659.45	1.38%
Nephrocare Health	690.15	1.27%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Senores Pharmaceutic	1,314	-6.91%
Panacea Biotec	420.90	-2.86%
Shilpa Medicare	609.20	-1.88%
Suven Life Sciences	305.95	-1.84%
Tarsons Products	315.90	-1.56%

News about BSE Healthcare

Jul, 2026

Aurobindo Pharma moves up on entering into non-exclusive voluntary licensing agreement with MSD

Aurobindo Pharma is among a select group of global generic manufacturers to have signed this agreement

Jul, 2026

Aurobindo Pharma enters into non-exclusive voluntary licensing agreement with MSD

Aurobindo Pharma is among a select group of global generic manufacturers to have signed this agreement

Jul, 2026

Dr. Lal Pathlabs - Quaterly Results

The company witnessed a 19.31% growth in the revenue at Rs. 7644.00 millions for the quarter ended June 2026 as compared to Rs. 6407.00 millions during the year-ago period.The company has announced a 28.31% increase in its profits to Rs . 1659.00 millions for the quarter ended June 2026 compared to Rs. 1293.00 millions in the corresponding quarter in the previous year.Operating Profit saw a handsome growth to 2684.00 millions from 2097.00 millions in the quarter ended June 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202606	202506	% Var	202606	202506	% Var	202603	202503	% Var
Sales	7644.00	6407.00	19.31	7644.00	6407.00	19.31	26476.00	23516.00	12.59
Other Income	299.00	263.00	13.69	299.00	263.00	13.69	1127.00	1115.00	1.08
PBIDT	2684.00	2097.00	27.99	2684.00	2097.00	27.99	8664.00	7770.00	11.51
Interest	61.00	45.00	35.56	61.00	45.00	35.56	220.00	215.00	2.33
PBDT	2623.00	2052.00	27.83	2623.00	2052.00	27.83	8143.00	7555.00	7.78
Depreciation	400.00	328.00	21.95	400.00	328.00	21.95	1541.00	1342.00	14.83
PBT	2223.00	1724.00	28.94	2223.00	1724.00	28.94	6602.00	6213.00	6.26
TAX	564.00	431.00	30.86	564.00	431.00	30.86	1520.00	1240.00	22.58
Deferred Tax	-9.00	22.00	-140.91	-9.00	22.00	-140.91	14.00	-393.00	-103.56
PAT	1659.00	1293.00	28.31	1659.00	1293.00	28.31	5082.00	4973.00	2.19
Equity	1676.00	838.00	100.00	1676.00	838.00	100.00	1676.00	836.00	100.48
PBIDTM(%)	35.11	32.73	7.28	35.11	32.73	7.28	32.72	33.04	-0.96

Jul, 2026

Laurus Labs - Quaterly Results

The company witnessed a 22.64% growth in the revenue at Rs. 17571.60 millions for the quarter ended June 2026 as compared to Rs. 14327.50 millions during the year-ago period.Profit for the quarter ended June 2026 rises by 83.59% to Rs. 2899.60 millions from Rs. 1579.40 millions.Operating profit for the quarter ended June 2026 rose to 5191.30 millions as compared to 3489.00 millions of corresponding quarter ended June 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202606	202506	% Var	202606	202506	% Var	202603	202503	% Var
Sales	17571.60	14327.50	22.64	17571.60	14327.50	22.64	60890.70	52169.80	16.72
Other Income	200.70	215.20	-6.74	200.70	215.20	-6.74	774.30	1004.70	-22.93
PBIDT	5191.30	3489.00	48.79	5191.30	3489.00	48.79	15156.90	10448.00	45.07
Interest	352.00	438.90	-19.80	352.00	438.90	-19.80	1429.60	1822.00	-21.54
PBDT	4839.30	3050.10	58.66	4839.30	3050.10	58.66	13727.30	8626.00	59.14
Depreciation	957.60	935.70	2.34	957.60	935.70	2.34	3786.40	3587.90	5.53
PBT	3881.70	2114.40	83.58	3881.70	2114.40	83.58	9940.90	5038.10	97.31
TAX	982.10	535.00	83.57	982.10	535.00	83.57	2536.10	1234.20	105.49
Deferred Tax	-50.40	-61.60	-18.18	-50.40	-61.60	-18.18	-315.10	-304.20	3.58
PAT	2899.60	1579.40	83.59	2899.60	1579.40	83.59	7404.80	3803.90	94.66
Equity	1080.50	1079.60	0.08	1080.50	1079.60	0.08	1079.70	1078.50	0.11
PBIDTM(%)	29.54	24.35	21.32	29.54	24.35	21.32	24.89	20.03	24.29

Jul, 2026

Cipla surges despite reporting 39% fall in Q1 consolidated net profit

Consolidated total income of the company increased by 1.58% to Rs 7,330.18 crore in Q1FY27

Jul, 2026

Sun Pharmaceutical Industries informs about press release

Sun Pharmaceutical Industries has informed that it enclosed a copy of the press release titled ‘Sun Pharma Notes Organon Shareholder Approval for Proposed Acquisition,’ which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.

Track Now:

5 Star Companies Large Cap Companies Mid Cap Companies Small Cap Companies Nifty Microcap Companies Top IT Companies Tax saver funds Analyze your Equity Funds Nifty Index Funds

BSE Healthcare FAQs

You can use different criterias to arrive at the list of best stocks in the BSE Healthcare company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the BSE Healthcare companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Sun Pharma Advanced Research Company Ltd. (S)	Not Good	213	6,974	4.49	5.23	4.68	282
Sanofi Consumer Healthcare India Ltd. (S)	Not Good	4,678	10,773	41.77	23.84	29.49	71.09
Wanbury Ltd. (S)	Very Good	327	1,157	17.50	8.01	12.67	69.35
Glaxosmithkline Pharmaceuticals Ltd. (M)	Very Good	2,554	43,202	41.70	18.92	28.74	45.95
Procter & Gamble Health Ltd. (S)	Very Good	6,798	11,257	34.43	21.46	23.36	43.64

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Acutaas Chemicals Ltd. (S)	Very Good	3,325	27,579	191
Laurus Labs Ltd. (M)	Very Good	1,721	92,623	105
Granules India Ltd. (S)	Very Good	845	20,878	79.76
Sai Life Sciences Ltd. (S)	Very Good	1,278	27,347	53.73
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,989	1,90,832	39.27
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Health X Platform Ltd. (S)	Not Good	310	985	0.00	3.64	-1233.10	110
Fischer Medical Ventures Ltd. (S)	Not Good	37.50	2,464	0.00	7.89	-478.47	96.10
Sun Pharma Advanced Research Company Ltd. (S)	Not Good	213	6,974	4.49	5.23	4.68	49.34
3B Blackbio Dx Ltd. (S)	Somewhat Good	1,283	1,112	22.54	4.07	15.33	46.29
Acutaas Chemicals Ltd. (S)	Very Good	3,325	27,579	69.39	15.81	47.63	32.80

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Max Healthcare Institute Ltd. (M)	N/A	1,115	1,08,476	75.20	10.23	46.01	155
Yatharth Hospital & Trauma Care Services Ltd. (S)	Very Good	845	8,132	85.24	5.02	49.92	138
3B Blackbio Dx Ltd. (S)	Somewhat Good	1,283	1,112	22.54	4.07	15.33	132
Artemis Medicare Services Ltd. (S)	Somewhat Good	277	4,408	42.61	5.07	20.59	79.02
Novartis India Ltd. (S)	Somewhat Good	1,640	4,023	41.14	4.73	24.19	54.56

You have 8 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

BSE Healthcare Companies

News about BSE Healthcare

Aurobindo Pharma moves up on entering into non-exclusive voluntary licensing agreement with MSD

Aurobindo Pharma enters into non-exclusive voluntary licensing agreement with MSD

Dr. Lal Pathlabs - Quaterly Results

Laurus Labs - Quaterly Results

Cipla surges despite reporting 39% fall in Q1 consolidated net profit

Sun Pharmaceutical Industries informs about press release

Track Now:

Trending Blogs

BSE Healthcare FAQs

How to select the top BSE Healthcare stocks based on RoE?

What are the best-performing stocks in the BSE Healthcare index?

Which BSE Healthcare stocks have the highest revenue growth in the past five years?

Which BSE Healthcare stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.